Company Filing History:
Years Active: 2018-2023
Title: Bettina Kiefmann: Innovator in Vaccine Development
Introduction
Bettina Kiefmann is a prominent inventor based in Vienna, Austria. She has made significant contributions to the field of vaccine development, particularly in the area of viral infections. With a total of 4 patents to her name, Kiefmann is recognized for her innovative approaches to combating serious health issues.
Latest Patents
Kiefmann's latest patents include groundbreaking work on CMV vaccines. These patents describe genetically modified arenaviral vectors that are suitable for the prevention and treatment of cytomegalovirus infections and reactivation. The inventions also encompass pharmaceutical compositions and methods aimed at treating these infections. Additionally, she has developed HPV vaccines that utilize genetically modified arenaviruses to target neoplastic diseases or cancer. This work includes pharmaceutical compositions and methods for preventing or treating infections associated with oncogenic viruses, particularly Human Papillomavirus (HPV).
Career Highlights
Bettina Kiefmann is currently associated with Hookipa Biotech GmbH, where she continues her research and development efforts. Her work has been instrumental in advancing the understanding and treatment of viral infections, contributing to public health initiatives.
Collaborations
Kiefmann collaborates with notable professionals in her field, including Klaus Orlinger and Thomas P Monath. These partnerships enhance her research capabilities and broaden the impact of her innovations.
Conclusion
Bettina Kiefmann stands out as a leading inventor in the realm of vaccine development. Her contributions to CMV and HPV vaccines reflect her commitment to addressing critical health challenges. Through her work, she continues to pave the way for future advancements in medical science.